Astellas may buy mitochondria start-up Mitokyne as part of R&D alliance

Astellas's new research partnership with the private US venture Mitokyne is in line with the Japanese firm's revised R&D strategy, under which it is making more use of external expertise and moving into new therapeutic areas.